Clinical Trials on Aura in France

Total 15 results

Assistance Publique - Hôpitaux de Paris

Recruiting

Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room

Migraine | Headache | Migraine Without Aura | Migraine With Aura

France
University Hospital, Toulouse

Completed

Brainstem Grey Matter and Cerebral Autoregulation in Migraine With Aura. (MINOTAURE)

Migraine With Aura

France
Centre Hospitalier Universitaire de Nice

Unknown

Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura (APAM)

Migraine With Aura

France
University Hospital, Toulouse

Completed

Interest of the T2 * Sequence in MRI for the Diagnosis of Migraine Aura in the Acute Phase. (MARIE)

Migraine Aura

France
Centre Hospitalier Universitaire de Nīmes

Recruiting

Brain Connectome for Acupuncture-treated Migraine Patients (ACU-BRAIN)

Acupuncture Therapy | Migraine Without Aura

France
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study

Migraine Without Aura | Migraine With Aura

Spain, France, Italy, Netherlands, Turkey, Belgium, Hungary, Czechia, Denmark, Germany, Greece, Norway, Portugal, Sweden
Solvay Pharmaceuticals
Nektar Therapeutics

Completed

Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache

Migraine Without Aura | Migraine With Aura

United States
Remedee SA

Completed

Migraine STImulation Crisis of Migraine (MISTIC)

Migraine Without Aura

France
University Hospital, Montpellier

Active, not recruiting

Sensitivity to Acute Cerebral Ischemia in Migrainers (SAMCO-MIG)

Ischemic Stroke | Migraine | Migraine With Aura

France
Satsuma Pharmaceuticals, Inc.

Completed

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine (EMERGE)

Migraine | Migraine Without Aura | Migraine With Aura

United States
Satsuma Pharmaceuticals, Inc.

Completed

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine (SUMMIT)

Migraine | Migraine Without Aura | Migraine With Aura

United States
Integra LifeSciences Corporation

Completed

Duragen® Secure Post Marketing Clinical Follow-up (PMCF)

Surgery | Dura Mater Nick Cut or Tear

France, Spain, United Kingdom, Germany
Ethicon, Inc.
OMRIX Biopharmaceuticals

Completed

A Study to Evaluate the Safety and Effectiveness of EVICEL as an Adjunct to Sutured Dural Repair

Dura Defects

Belgium, Finland, France, Germany, Netherlands, United Kingdom
Allergan

Completed

Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine (ACHIEVE I)

Migraine, With or Without Aura

United States
Allergan

Completed

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

Migraine, With or Without Aura

United States

Clinical Trials on Aura in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations